Toxoplasmosis as an Early Complication of Allogeneic Hematopoietic Cell Transplantation

Archive ouverte

Robin, Christine | Leclerc, Mathieu | Angebault, Cécile | Redjoul, Rabah | Beckerich, Florence | Cabanne, Ludovic | Foulet, Francoise | Pautas, Cécile | Toma, Andréa | Maury, Sébastien | Botterel, Francoise | Cordonnier, Catherine

Edité par CCSD ; Elsevier -

International audience. Among 419 consecutive allogeneic hematopoietic cell transplant recipients, we observed 17 (4.0%) cases of toxoplasmosis at a median time of day 45 (range, 6 to 322) after transplant. Seven of these 17 cases occurred before day 30 after transplant. Because of the lack of PCR screening and trimethoprim-sulfamethoxazole prophylaxis before engraftment, the diagnosis of toxoplasmosis was late, and 5 of these 7 patients died. Analyzing these cases, early Toxoplasma blood PCR screening, starting from transplant, is crucial.

Suggestions

Du même auteur

Long-Term Immunity to Measles after Allogeneic Hematopoietic Cell Transplantation: Factors Associated with Seroprotection before Revaccination

Archive ouverte | Robin, Christine | CCSD

International audience

Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients

Archive ouverte | Robin, Christine | CCSD

International audience. BACKGROUND: Cytomegalovirus (CMV) infection and disease (CMV episodes) are global concerns after allogeneic hematopoietic stem cell transplantation (HSCT). They affect survival, both by direc...

Immunogenicity and safety of the meningococcal B recombinant (4CMenB) vaccine in allogeneic hematopoietic cell transplantation recipients

Archive ouverte | Robin, Christine | CCSD

International audience. ObjectivesDespite a high risk of invasive meningococcal (Men) disease, there is no published data on any MenB vaccine after hematopoietic cell transplantation (HCT). We investigated the immun...

Chargement des enrichissements...